These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 17971014

  • 21. Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met.
    Onimaru Y, Tsukasaki K, Murata K, Imaizumi Y, Choi YL, Hasegawa H, Sugahara K, Yamada Y, Hayashi T, Nakashima M, Taguchi T, Mano H, Kamihira S, Tomonaga M.
    Int J Oncol; 2008 Oct; 33(4):697-703. PubMed ID: 18813782
    [Abstract] [Full Text] [Related]

  • 22. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.
    Shia S, Stamos J, Kirchhofer D, Fan B, Wu J, Corpuz RT, Santell L, Lazarus RA, Eigenbrot C.
    J Mol Biol; 2005 Mar 11; 346(5):1335-49. PubMed ID: 15713485
    [Abstract] [Full Text] [Related]

  • 23. Transforming growth factor-beta1-antisense modulates the expression of hepatocyte growth factor/scatter factor in keloid fibroblast cell culture.
    Naim R, Naumann A, Barnes J, Sauter A, Hormann K, Merkel D, Aust W, Braun T, Bloching M.
    Aesthetic Plast Surg; 2008 Mar 11; 32(2):346-52. PubMed ID: 18087663
    [Abstract] [Full Text] [Related]

  • 24. Hepatocyte growth factor and macrophage-stimulating protein are upregulated during excisional wound repair in rats.
    Cowin AJ, Kallincos N, Hatzirodos N, Robertson JG, Pickering KJ, Couper J, Belford DA.
    Cell Tissue Res; 2001 Nov 11; 306(2):239-50. PubMed ID: 11702235
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Effect of HAI-1 over-expression on in vitro growth and migration/motility of SW620 cells].
    Cao J, Ye JJ.
    Shi Yan Sheng Wu Xue Bao; 2005 Jun 11; 38(3):183-9. PubMed ID: 16044910
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Changes in plasma levels of hepatocyte growth factor and its associated factors during pregnancy.
    Watanabe T, Sakata Y, Matsubara S, Yamagishi T, Nagaike K, Kuwata T, Suzuki M.
    J Obstet Gynaecol Res; 2006 Feb 11; 32(1):10-4. PubMed ID: 16445520
    [Abstract] [Full Text] [Related]

  • 31. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
    Matsumoto K, Nakamura T, Sakai K, Nakamura T.
    Proteomics; 2008 Aug 11; 8(16):3360-70. PubMed ID: 18646008
    [Abstract] [Full Text] [Related]

  • 32. Hepatocyte growth factor-regulated genes in differentiated RAW 264.7 osteoclast and undifferentiated cells.
    Gaasch JA, Bolwahnn AB, Lindsey JS.
    Gene; 2006 Mar 15; 369():142-52. PubMed ID: 16403606
    [Abstract] [Full Text] [Related]

  • 33. Overview: acute and chronic wounds.
    Whitney JD.
    Nurs Clin North Am; 2005 Jun 15; 40(2):191-205, v. PubMed ID: 15924889
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The role of hepatocyte growth factor in the humoral regulation of inguinal hernia closure.
    Ting AY, Huynh J, Farmer P, Yong EX, Hasthorpe S, Fosang A, King S, Deshpande A, Hutson J.
    J Pediatr Surg; 2005 Dec 15; 40(12):1865-8. PubMed ID: 16338307
    [Abstract] [Full Text] [Related]

  • 36. Alternative proteolytic processing of hepatocyte growth factor during wound repair.
    Buchstein N, Hoffmann D, Smola H, Lang S, Paulsson M, Niemann C, Krieg T, Eming SA.
    Am J Pathol; 2009 Jun 15; 174(6):2116-28. PubMed ID: 19389925
    [Abstract] [Full Text] [Related]

  • 37. Expression of hepatocyte growth factor activator inhibitor type 1 in endothelial cells.
    Akiyama Y, Nagai M, Komaki W, Marutsuka K, Asada Y, Kataoka H.
    Hum Cell; 2006 Aug 15; 19(3):91-7. PubMed ID: 17204092
    [Abstract] [Full Text] [Related]

  • 38. [Hepatocyte growth factor (HGF) reduces the expression of profibrotic factors in human isolated glomeruli].
    Esposito C, Parilla B, De Mauri A, Cornacchia F, Fasoli G, Foschi A, Mazzullo T, Plati AR, Scudellaro R, Dal Canton A.
    G Ital Nefrol; 2003 Aug 15; 20(4):376-80. PubMed ID: 14523898
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F, Engst S, Yamaguchi K, Yu P, Won KA, Mock L, Lou T, Tan J, Li C, Tam D, Lougheed J, Yakes FM, Bentzien F, Xu W, Zaks T, Wooster R, Greshock J, Joly AH.
    Cancer Res; 2009 Oct 15; 69(20):8009-16. PubMed ID: 19808973
    [Abstract] [Full Text] [Related]

  • 40. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A, Boekschoten MV, Klein C, Borowiak M, Birchmeier C, Gassler N, Wasmuth HE, Müller M, Trautwein C, Streetz KL.
    Gastroenterology; 2009 Jul 15; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.